UBS’s Cardinal Health CAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2014
Q3
$6.16M Sell
82,200
-13,000
-14% -$946K ﹤0.01% 1831
2014
Q2
$6.53M Buy
95,200
+90,000
+1,731% +$6.13M 0.01% 1718
2014
Q1
$364K Sell
5,200
-17,700
-77% -$1.23M ﹤0.01% 4565
2013
Q4
$1.53M Buy
22,900
+21,200
+1,247% +$1.3M ﹤0.01% 3084
2013
Q3
$89K Sell
1,700
-13,900
-89% -$706K ﹤0.01% 6141
2013
Q2
$736K Buy
+15,600
New +$712K ﹤0.01% 3664

Other funds holding CAH

UBS's CAH Position: Q3 2014 in Review

UBS increased its Cardinal Health (CAH) stake by 5.4% in Q3 2014, buying an estimated $1.41M and bringing the position to 374,358 shares worth $28M. The position accounts for 0.02% of the portfolio, ranked #753.

UBS first reported a position in CAH in Q2 2013 and has held it in 6 quarters since. The position peaked at $32.3M in Q3 2013. 643 funds tracked by Wall St. Rank hold CAH as of Q3 2014.

  • UBS held 374,358 shares of Cardinal Health worth $28M as of Q3 2014.
  • UBS bought 19,339 Cardinal Health shares in Q3 2014, an estimated $1.41M.
  • Cardinal Health made up 0.02% of UBS's portfolio in Q3 2014, its #753 holding.
  • UBS first reported a position in Cardinal Health in Q2 2013 and has held it in 6 quarters since.
  • UBS's Cardinal Health position peaked at $32.3M in Q3 2013.
  • 643 funds tracked by Wall St. Rank held Cardinal Health as of Q3 2014.

Based on UBS's 13F filing for Q3 2014, filed 12 Nov 2014.